Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-08-26

Clinical Trial Update: Pessary as Adjunctive Therapy to Cerclage for the Prevention of Preterm Birth [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pessary as adjunctive therapy to cerclage for preventing preterm birth was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Federico II University | Conditions: Preterm Birth | Phase 3 | Status: WITHDRAWN